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 Identification of PPARγ agonists in root extracts of purple coneflower 
(Echinacea purpurea) by bioassay-guided fractionation 
Rime Bahij El-Houri1*, X. C. Fretté1, K. B. Christensen1, D. Kotowska2, K. Grevsen3, K. Kristiansen2  and L. P. Christensen1 
Introduction     
One of the major characteristics of type 2 diabetes (T2D) is insulin resistance, which is often treated by insulin sensitizing drugs 
such as thiazolidinediones (TZDs). The primary target for the TZDs is the peroxisome proliferator-activated receptor PPARγ. 
However, critical side effects of TZDs can occur, as they are full PPARγ agonists. Partial PPARγ agonists are associated with fewer 
side effects but still may maintain the effect on insulin resistance. Alkamides are very similar in chemical structure to natural 
ligands for the PPARγ such as fatty acids, and hence are potential PPARγ agonists. Recently, a new C16-alkamide able to activate 
PPARγ with no concurrent stimulation of adipocyte differentiation, and able to increase insulin-stimulated glucose uptake was 
isolated from the flowers of purple coneflower (Echinacea purpurea) [1]. In our search for new partial PPARγ agonists the roots 
of purple coneflower, which is a rich source for alkamides, was investigated. 
A 
C 
Extraction and isolation 
5 kg fresh roots of purple coneflower were extracted overnight with dichloromethane 
(DCM). The dried extract was subjected to bioassay-guided chromatographic fractionation. 
First step was a separation by flash column chromatography using a n-hexane–ethyl 
acetate gradient resulting in 10 fractions (A–J). Two fractions (D and H) showed promising 
bioactivity in a dose-dependent manner. LC-MS analysis revealed that these two fractions 
primarily contained known and unknown alkamides (data not shown).  
PPARγ transactivation assay 
The ability of the DCM extract to activate the PPARγ was 
tested in a luciferase-based PPAR transactivation assay 
using mouse embryonic fibroblasts transfected with a 
luciferase reporter plasmid, a transfection control plasmid, 
and an expression plasmid. Degree of activation was 
determined by a luminometer and compared to a positive 
control, Rosiglitazone (Rosi). The DCM extract was found to 
activate PPARγ in a dose-dependent manner (1–100 
μg/mL)  without stimulating adipocyte differentiation at 
100 μg/mL. Figures 1 and 2 show fold activations of PPARγ 
by the DCM extract with vehicle (DMSO) set to 1.0 and 
corresponding results from adipocyte differentiation assay 
(DEX protocol).  
Fig. 1 
Fig. 2 
Stimulation of glucose uptake in adipocytes 
The DCM extract and fractions D and H were tested for 
stimulation of insulin-dependent glucose uptake in 
adipocytes. Dose-dependent stimulation (0–100 nM) was 
observed for all three samples as shown in Figure 3. All 
results were compared to a positive control (Rosi) and 
vehicle (DMSO). Mature adipocytes were subjected to the 
extract/fractions and after 2 days glucose uptake was 
induced by insulin. Effect was measured using 14C-labeled 
glucose and afterwards radioactivity was determined by 
scintillation counting. 
Fig. 3 
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Conclusions and Perspectives 
 The DCM extract of the roots of purple coneflower showed promising activation of PPARγ in a dose-
dependent manner without stimulating adipocyte differentiation. 
 Bioassay-guided fractionation resulted in two alkamide-rich fractions, which were able to activate 
PPARγ and positively affected insulin-stimulated glucose uptake in adipocytes. 
 The results of this study clearly indicate that alkamides are partial PPARγ agonists with a potential in 
relation to the management of insulin resistance and T2D. Individual alkamides from the active 
fractions warrant further investigation for their PPARγ activating properties in order to identify the 
most active alkamides and hence, the most promising PPARγ agonists in coneflower roots. 
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